Turn Therapeutics appoints Robert R. Redfield as chief scientific officer
Turn Therapeutics appointed Robert R. Redfield as chief scientific officer to advance scientific and clinical strategy for GX-03.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.